Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CLDX
SLS
Add up to 3 more stocks
CLDX
Celldex Therapeutics, Inc.
-4.50%
$31.12-1.47Delayed quote: Oct 6, 2026, 3:40 PM EDT
Market Cap
$2.07B
52W Range
$22.10 - $45.14
SLS
SELLAS Life Sciences Group, Inc.
-2.31%
$11.36-0.27Delayed quote: Oct 6, 2026, 3:40 PM EDT
Market Cap
$2.11B
52W Range
$1.39 - $15.88
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.90 | 15.35 |
| P/S Ratio | 18490.56 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 0.0% |
| Operating Margin | -19160.0% | 0.0% |
| Net Margin | -268385.7% | 0.0% |
| ROE | -42.1% | -23.6% |
| ROA | -38.4% | -22.3% |
| ROIC | -45.2% | -25.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 11.82 | 18.83 |
| Quick Ratio | 11.82 | 18.83 |
| Debt/Equity | 0.01 | 0.01 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.